Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity.
Myosins
Neuronal interfaces
Neurotransmitter release
Synapsins
Synaptic vesicles
Journal
Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
10
4
2021
Statut:
ppublish
Résumé
More than a scientific paper or a review article, this is a remembrance of a unique time of science and life that the authors spent in Paul Greengard's laboratory at the Rockefeller University in New York in the 1980s and 1990s, forming the so-called synaptic vesicle group. It was a time in which the molecular mechanisms of synaptic transmission and the nature of the organelles in charge of storing and releasing neurotransmitter were just beginning to be understood. It was an exciting time in which the protein composition of synaptic vesicles started to be identified. It turned out that the interactions of synaptic vesicle proteins with the cytoskeleton and the presynaptic membrane and their modulation by protein phosphorylation represented an essential network regulating the efficiency of neurotransmitter release and thereby synaptic strength and plasticity. This is also a description of the distinct scientific journeys that the three authors took on going back to Europe and how they were strongly influenced by the generous and outstanding mentorship of Paul Greengard, his genuine interest in their lives and careers and the life-long friendship with him.
Identifiants
pubmed: 33706933
pii: S1054-3589(20)30063-6
doi: 10.1016/bs.apha.2020.09.007
pii:
doi:
Substances chimiques
Neurotransmitter Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
19-37Informations de copyright
© 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest statement The authors have no conflicts of interest to declare.